Cinchona alkaloid 2026-10-31
One of the related alkaloids obtained from cinchona bark. Different solubilities allow partial separation during crystallization and extraction.
Opium 2026-10-31
The 1864 preparations contain either crude opium or its aqueous Extractum Opii; those quantities must be distinguished from a quantity of isolated morphine. The following are the officinal opium preparations. Ratios for solids mean the mass fraction in the compounded preparation; liquid strengths specify mass per volume or the actual ingredients used.
- Emplastrum Opii: powdered opium in resin plaster: 1 in 10.
- Enema Opii: opium tincture 30 minims with starch decoction 2 fluid ounces. Thus the tincture is 1 volume to 32 volumes of vehicle, before mixing.
- Extractum Opii: aqueous solvent extraction of 1 avoirdupois pound of sliced opium with 6 Imperial pints of distilled water, in three successive portions, followed by evaporation. The prescribed starting quantities do not impose a fixed yield or a universal crude-drug-to-extract potency ratio.
- Extractum Opii Liquidum: Extractum Opii 1 avoirdupois ounce, distilled water 17 fluid ounces, rectified spirit 3 fluid ounces: 1 ounce of extract to the pint of liquid ingredients.
- Linimentum Opii: equal volumes of opium tincture and soap liniment: half the tincture's nominal opium strength.
- Pilula Opii: powdered opium with hard soap: 1 in 5 of the nominal pill ingredients.
- Pilula Plumbi cum Opio: powdered opium with lead acetate and confection of roses: 1 in 8.
- Pulvis Cretae Aromaticus cum Opio: powdered opium with aromatic chalk powder: 1 in 40.
- Pulvis Ipecacuanhae cum Opio: powdered opium with ipecacuanha and potassium sulfate: 1 in 10.
- Pulvis Kino cum Opio: powdered opium with kino and cinnamon: 1 in 20.
[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). Papaverceae, part 2, British formulas outside the bracketed American additions; underlying revision dated May 1864
- Tinctura Camphorae cum Opio: opium 40 grains to 1 Imperial pint of proof spirit, with benzoic acid, camphor and anise oil: 2 grains of opium per fluid ounce.
- Opium tincture, Tinctura Opii: powdered opium 1½ avoirdupois ounces to 1 Imperial pint of proof spirit. Nominally this is 32.8125 grains per fluid ounce, or approximately 1 grain per 14.63 minims.
- Trochisci Opii: 72 grains of Extractum Opii in 720 lozenges: one tenth of a grain of extract per lozenge.
- Unguentum Gallae cum Opio: powdered opium 32 grains added to 1 avoirdupois ounce of gall ointment. The actual nominal total is grains, giving 32/469.5 by mass, approximately 1 in 14.67; “32 grains to the ounce of ointment taken” is not 32 grains per final ounce.
- Vinum Opii: powdered opium 1½ avoirdupois ounces, sherry 1 Imperial pint: the tincture's nominal opium proportion, in a different solvent. This formula uses crude opium, not Extractum Opii.
[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). Papaverceae, part 3, British tincture, lozenge, ointment and wine formulas
The arithmetic uses the new avoirdupois ounce of 437.5 grains, not the old apothecaries' ounce of 480 grains. These are historical formulation proportions, not modern assays of morphine delivered after solvent extraction. Confectio Opii was omitted in 1864, and this edition's Vinum Opii contains no spices. The separate morphine hydrochloride preparations—Liquor Morphiae Hydrochloratis, Suppositoria Morphiae, Trochisci Morphiae, and Trochisci Morphiae et Ipecacuanhae—contain an isolated alkaloid salt rather than crude opium. [ref]
The Prescriber's Analysis of the British Pharmacopoeia by John Birkbeck Nevins (1864). pp. 11–12, 39 and 75–76
The compositions must be specified ingredient by ingredient; the two alkaloidal solutions contain 4 grains per nominal fluid ounce, but one contains a morphine salt and the other strychnine.
Pulvis Jalapae Compositus contains powdered jalap 5 avoirdupois ounces, potassium hydrogen tartrate 9 avoirdupois ounces, and powdered ginger 1 avoirdupois ounce. Thus the mass proportions are 5:9:1, and jalap supplies one third of the powder's mass. This is a compound purgative, not pure jalap resin. [ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). Convolvulaceae, Jalapa, compound powder
Pilula Scillae Composita contains powdered squill 1¼ avoirdupois ounces, powdered ginger, ammoniacum and hard soap 1 avoirdupois ounce each, with treacle 2 avoirdupois ounces, or sufficient to make a pill mass. Using the specified 2 avoirdupois ounces of treacle, the whole is 6¼ avoirdupois ounces and contains one fifth squill by mass. The allowance of sufficient treacle makes consistency a compounding requirement, not a claim that every moist pill batch has an analytically exact 20% squill content. [ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). Liliaceae, British compound squill pill, distinguished from bracketed American formula
Liquor Morphiae Hydrochloratis contains morphine hydrochloride 4 grains, dilute hydrochloric acid 8 minims, rectified spirit 2 fluid drachms and distilled water 6 fluid drachms. Its conventional strength is ½ grain of morphine hydrochloride per fluid drachm, not ½ grain of free morphine. The small quantity of hydrochloric acid maintains an acid solution. [ref]
Liquor Strychniae contains strychnine 4 grains, dilute hydrochloric acid 6 minims, rectified spirit 2 fluid drachms and distilled water 6 fluid drachms. Dissolve the strychnine in the acid mixed with part of the water, using the prescribed assistance of heat, then add the spirit and remaining water. Its conventional strength is ½ grain of strychnine per fluid drachm. Acid promotes solubility by forming a soluble salt of the alkaloid. [ref]
For the last two solutions, the stated historical strengths use the nominal 8 fluid drachms of spirit and water. The extra few minims of dilute acid must still appear in the actual recipe; treating all ingredient volumes as perfectly additive would not give an exact modern analytical concentration.
Retain the original material, examine separate portions for arsenic and digitalin, and require corroboration beyond a single colour or deposit. One is an inorganic element; the other is a historical pharmaceutical preparation of organic cardiac poisons. A procedure suited to one can destroy or lose the other.
Record the receipt, container, quantity and condition of the stomach contents. Preserve a sealed portion unchanged. Mix the remainder sufficiently to obtain representative aliquots, retaining solid particles as well as liquid. Record the portions consumed by each test and retain the resulting preparations. Test the reagents separately and include an unpoisoned comparison material where available. An analyst must distinguish poison originally present from contamination introduced by apparatus, acids or metals.
For arsenic detection, a useful period screen is deposition on clean copper warmed in an acidified portion of the material. A dark coating is only presumptive: other substances, including antimony, can interfere. Wash and dry the coated copper, then heat it in a small glass tube, examining the cooler portion for a sublimate of arsenic trioxide and its characteristic crystals under a microscope. A separately prepared clear extract allows corroborating reactions, such as the yellow arsenic trisulfide precipitate and the appropriate silver reaction. An 1844 primary account already stressed both reagent purity and the danger of confusing arsenic with other metals.[ref]
On Arsenic as a Poison; Its Tests and Antidote by E. J. Shearman. 1844, pp.3–4: reagent controls, copper deposition, sublimation and confirmatory tests; the author's speculative reaction mechanism is not adopted here
A second classical approach converts the suspected arsenic into volatile arsine in a hydrogen-generating apparatus and decomposes it in a heated glass tube, producing a metallic mirror. This separates a volatile product from much of the original organic material. A mirror alone is insufficient, since antimony can give a similar deposit; establish the deposit's identity by further chemistry. The initial blank must include the very zinc and acid used in the examination. The apparatus produces extremely poisonous gas: this is an explanation of historical laboratory evidence, not a procedure for an uncontained demonstration. The original method of James Marsh explains the value of separating the poison in gaseous form; later confirmation must still distinguish arsenic from interfering material.[ref]
Separation of Arsenic by James Marsh. Opening pages and apparatus description: hydrogen-based separation from animal and vegetable material
For digitalin, work on a fresh aliquot without mineralizing it. Use an alcoholic extraction, filter away coarse material, concentrate gently, and retain rather than discard fractions until their behaviour has been checked against a reference preparation. “Digitalin” did not denote one uniform pure compound: a contemporary 1864 report distinguished preparations with markedly different solubilities. Accordingly, a negative result after one solvent partition is inconclusive; it would be particularly misleading to assume that the substance must follow the acid–base extraction behaviour of a simple alkaloid.[ref]
Chemical News volume 10 (1864). 27 August, pp.99–100, “On Digitaline”: different pharmaceutical preparations and solubilities
Colour reactions could support the examination of a cleaned extract. Contemporary work described a brown or reddish colour with sulfuric acid, changed to violet by bromine vapour; the hydrochloric-acid green colour was already acknowledged to lack specificity. Compare a reference and a blank under the same conditions. Colour in a dirty stomach extract is not an identification, and tasting an unknown extract is not an acceptable analytical test.[ref]
Chemical News volume 10 (1864). “On Digitaline”, report of the sulfuric-acid and bromine reaction and the limitations of the hydrochloric-acid colour
A particularly relevant development available before this examination was the physiological test investigated by Charles Hilton Fagge and Thomas Stevenson in 1865. An extracted fraction was compared with known digitalin using the response of a frog's heart. The informative effect was irregular beating followed by arrest with the cardiac ventricle pale and firmly contracted, rather than mere illness or death. Crucially, their experiments also showed that ordinary human stomach contents could injure frogs, and other cardiac poisons could resemble digitalin. A solvent blank, a comparable unpoisoned extract and a reference poison therefore matter. These are historical experiments, not a proposal to repeat animal testing for this solution.[ref]
On the Application of Physiological Tests for Certain Organic Poisons, and Especially Digitaline by Charles Hilton Fagge and Thomas Stevenson. Royal Society archive AP/47/2, 1865: experiments with reference solutions and extracts
[ref]On Tests for Aconite and Digitaline in The British and Foreign Medico-Chirurgical Review (1866). pp.454–455: contracted pale ventricle, related cardiac poisons, and toxicity of ordinary gastric contents
The defensible conclusion combines extraction behaviour, chemical reactions, physiological specificity and the clinical circumstances, acknowledging uncertainty if these disagree. A modern laboratory would instead seek specific validated instrumental identification, for example chromatography coupled to mass spectrometry for an identified cardiac glycoside, with reference material and controls. That later capability must not be credited to an 1866 examiner.[ref]
Standard for Identification Criteria in Forensic Toxicology. Identification criteria: reliability requires appropriate analytical characteristics rather than one nonspecific response
Opium was chiefly used to relieve pain, procure sleep, suppress troublesome cough and restrain diarrhoea; each effect can relieve suffering while also creating a hazard. It is a mixture of alkaloids, not a single standardized modern drug. Preparations such as laudanum cannot be treated as interchangeable volumes of “a sedative”. Morphine and codeine account for important pharmacological effects, but historical extracts varied.
For pain, the useful objective is relief sufficient for rest and function. A person exhausted by severe pain may sleep after analgesia; that is different from using ever-increasing sedation to suppress an unexplained illness. In an 1866 explanation, opium might therefore accompany treatment of painful inflammatory disease or severe colic. It could palliate suffering even when no curative treatment existed. It did not follow that a quieter person had recovered from pericarditis, obstruction or infection.
For cough, reducing an exhausting, unproductive symptom was the historical aim. But suppressing a protective cough where clearance of secretions or maintenance of breathing is already impaired can be harmful. For diarrhoea, slowing intestinal transit reduces the number of stools; it does not restore lost fluid or eliminate an infectious cause. The modern pharmacological description of opium tincture specifically links its antidiarrhoeal effect to altered intestinal motility and greater absorption of water from intestinal contents.[ref] Reduced output is therefore not by itself proof that the underlying disease is improving.
Historical uses also extended to spasmodic disorders and states called nervous excitement. These broad categories mixed different causes. A drug producing drowsiness could conceal deterioration, and neither tetanus nor alcohol withdrawal becomes adequately treated merely because the person is less visibly agitated. The contemporary medical debate openly questioned when opium was useful in such different conditions as delirium tremens, dysentery and cholera.[ref]
Introductory Address at the Public Opening of the Medical Session, 1866–67 by William Tennant Gairdner. p. 294, disputed indications for opium in delirium tremens, dysentery and cholera
Modern correction: use a defined drug for a defined indication, with monitoring of benefit and toxicity. Properly prescribed opioids remain important for selected severe pain and palliation; crude opium is not a general remedy for sleeplessness, agitation or an undiagnosed abdomen. Major hazards include respiratory depression, excessive sedation, nausea, constipation, physical dependence and harmful interactions with other depressant drugs. Extra care is needed with renal or hepatic impairment. Gastrointestinal obstruction, particularly paralytic ileus, and significant respiratory compromise can preclude routine opioid use; the details depend on the drug and clinical setting.[ref]
Morphine by MedlinePlus. Important warning; precautions and adverse effects
[ref]Morphine Sulfate prescribing information (FDA). Contraindications; respiratory depression, gastrointestinal effects and special-risk groups
In sustained palliative treatment, review analgesia and adverse effects and anticipate constipation, rather than waiting for it to become severe.[ref]Prepare quinine sulfate by acidic extraction of cinchona bark, alkaline precipitation of the quinine base, conversion into the sulfate, and purification by crystallization. “Quinia” is the historical name for quinine.
The 1867 process starts with one pound of yellow cinchona bark in coarse powder, three fluid ounces of hydrochloric acid, four pints of solution of sodium hydroxide, and sufficient distilled water and diluted sulfuric acid. The hydrochloric acid is diluted with ten pints of distilled water. The bark is first moistened with diluted sulfuric acid, macerated for twenty-four hours with occasional stirring, and then exhausted in a percolator with the diluted hydrochloric acid. The historical endpoint is disappearance of the bitter character of the emerging liquid. This describes the period's test, not an instruction to taste an unidentified medicinal material.[ref]
British Pharmacopoeia by the General Medical Council (1867). “Quiniæ sulphas”, pp. 268–269, ingredients and extraction
The soluble alkaloid salts enter the percolate. Adding solution of sodium hydroxide liberates the much less water-soluble quinine base. After settling, the liquid is decanted and the precipitate collected on a filter and washed with cold distilled water until the washings cease to be coloured. The precipitate is then treated warm with distilled water and diluted sulfuric acid, added gradually to obtain a neutral liquid with nearly all the precipitate dissolved. The hot solution is filtered through paper, the filter washed with distilled water, and the filtrate concentrated until a surface film appears. It is then set aside for crystallization; the crystals are dried on filter paper without applied heat. This is a separation of a naturally occurring alkaloid, not a synthesis of the quinine skeleton.
Writing for the quinine base, the central changes are:The successive changes in solubility explain the apparatus: a percolator washes soluble salts out of the powder; a filter retains the liberated base; a heated porcelain vessel dissolves the crude base as its sulfate; cooling then recovers the less soluble crystals. Other cinchona alkaloids can accompany the product, which is why appearance and bitterness are insufficient evidence of purity.
- Appearance and solubility: filiform, silky, white crystals, sparingly soluble in water, with the characteristic bluish appearance of the solution. A little dilute acid increases solubility. The visible blue phenomenon is associated with quinine fluorescence.
- Sulfate identity: barium chloride gives a white precipitate insoluble in nitric acid. The precipitate is barium sulfate.
- Quinine identity: treating the solution first with chlorine water and then with Ammonia gives an emerald-green colour, the thalleioquin test. A positive colour reaction establishes a characteristic chemical response, rather than proving that no other alkaloid is present.
- Strong-acid colour test: dissolution in pure sulfuric acid gives only a faint yellowish tint, with no further colour change on gentle warming. Marked colouring suggests foreign organic matter, such as sucrose or other readily altered material.
- Acid dissolution and liberation of the base: ten grains with ten minims of diluted sulfuric acid and half a fluid ounce of water form a complete solution; Ammonia then gives a white precipitate. Material insoluble under the acid conditions would fail the dissolution requirement.
- Ether separation: the precipitated base must pass into diethyl ether on shaking the whole with half a fluid ounce of diethyl ether, without crystalline matter remaining at the boundary between the two liquid layers. Less ether-soluble cinchona alkaloids, particularly cinchonine, can leave material at this boundary. This is a period screening test, not a modern quantitative determination of every related impurity.
- Water of crystallization: twenty-five grains lose 3.6 grains on drying at , equivalent to . This checks excessive moisture or a materially different degree of hydration.
The historical quantity and endpoint requirements belong to the 1867 monograph.[ref]
British Pharmacopoeia by the General Medical Council (1867). “Quiniæ sulphas”, pp. 268–269, “Characters and Tests”
Its formula represents the then-described heptahydrate; the current “Quinine sulfate” instead specifies a dihydrate and modern tests for related cinchona alkaloids. The modern specification explains that distinction; the exam's historical tests remain those listed above.[ref]International Pharmacopoeia by the World Health Organization. 12th edition, 2024, “Quinine sulfate (Quinini sulfas)”, formula, loss on drying and related cinchona alkaloids
Quinine 2026-10-31
An alkaloid isolated from cinchona bark, historically called quinia. The free base and quinine sulfate have different solubilities.